ATF6 and hematopoietic and lymphoid cell neoplasm: The B-cell specific TF POU2F2 was predicted to inhibit tumor cell apoptosis and enhance transcription, and IRF4 in combination with ATF6 was predicted to play an important role in the development of hematopoietic neoplasm (Figure 4C).